Compare · BDX vs MOTS
BDX vs MOTS
Side-by-side comparison of Becton Dickinson and Company (BDX) and Motus GI Holdings Inc. (MOTS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BDX and MOTS operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- BDX is the larger of the two at $42.44B, about 2624.0x MOTS ($16.2M).
- BDX has hit the wire 15 times in the past 4 weeks while MOTS has been quiet.
- BDX has more recent analyst coverage (25 ratings vs 1 for MOTS).
- Company
- Becton Dickinson and Company
- Motus GI Holdings Inc.
- Price
- $149.10+2.61%
- $0.18-30.42%
- Market cap
- $42.44B
- $16.2M
- 1M return
- -5.16%
- -
- 1Y return
- -12.07%
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2018
- News (4w)
- 15
- 0
- Recent ratings
- 25
- 1
Becton Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Motus GI Holdings Inc.
Motus GI Holdings, Inc., a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with colonoscopy in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company was incorporated in 2016 and is based in Fort Lauderdale, Florida.
Latest BDX
- BD Achieves Excellence in Employee Well‑Being, Earning Top Industry Recognition
- Becton Dickinson and Company filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- BD Reimagines Central Line Insertion, Advancing Leadership in Patient Safety Through Breakthrough Vascular Access Technology
- BD Board Declares Dividend
- EVP, Chief Revenue Officer Feld Michael sold $11,244 worth of shares (74 units at $151.94) as part of a pre-agreed trading plan, decreasing direct ownership by 0.35% to 21,159 units (SEC Form 4)
- BD to Present at Bank of America Securities Health Care Conference
- BD Earns Industry Top Honors for Transparency, Resiliency and Partnership
- Goldman resumed coverage on Becton Dickinson with a new price target
- Becton Dickinson and Company filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- BD to Announce Financial Results for its Second Quarter of Fiscal 2026
Latest MOTS
- Amendment: SEC Form SC 13G/A filed by Motus GI Holdings Inc.
- SEC Form EFFECT filed by Motus GI Holdings Inc.
- SEC Form EFFECT filed by Motus GI Holdings Inc.
- SEC Form EFFECT filed by Motus GI Holdings Inc.
- SEC Form EFFECT filed by Motus GI Holdings Inc.
- SEC Form EFFECT filed by Motus GI Holdings Inc.
- SEC Form 15-12G filed by Motus GI Holdings Inc.
- SEC Form S-8 POS filed by Motus GI Holdings Inc.
- SEC Form S-8 POS filed by Motus GI Holdings Inc.
- SEC Form S-8 POS filed by Motus GI Holdings Inc.